Skip to Content

RAPAMUNE 0.5 mg (Rapamune 0.5 mg)

Generic Name: sirolimus

Pill with imprint RAPAMUNE 0.5 mg is Tan, Three-sided and has been identified as Rapamune 0.5 mg. It is supplied by Wyeth Laboratories.

Rapamune is used in the treatment of organ transplant, rejection prophylaxis; lymphangioleiomyomatosis and belongs to the drug classes mTOR inhibitors, selective immunosuppressants. Risk cannot be ruled out during pregnancy. Rapamune 0.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for RAPAMUNE 0.5 mg

Rapamune

Generic Name:
sirolimus
Imprint:
RAPAMUNE 0.5 mg
Strength:
0.5 mg
Color:
Tan
Shape:
Three-sided
Availability:
Prescription only
Drug Class:
MTOR inhibitors
Selective immunosuppressants
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Wyeth Laboratories
Inactive Ingredients:
sucrose
polyethylene glycol 8000
calcium sulfate
microcrystalline cellulose
magnesium silicate
titanium dioxide
magnesium stearate
povidone k29/32
lactose monohydrate
poloxamer 188
carnauba wax
ferric oxide yellow
alpha tocopherol acetate
glyceryl oleate
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
59762-1001 Greenstone LLC

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide